Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2018 1
2019 1
2020 1
2021 1
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Long-term functional outcomes after robot-assisted radical cystectomy with intracorporeal ileal orthotopic neobladder.
Pellegrino F, Scilipoti P, Rosiello G, Longoni M, Leni R, Basile G, Quarta L, Zaurito P, Re C, de Angelis M, Cattafi F, Burgio G, Gandaglia G, Montorsi F, Briganti A, Moschini M. Pellegrino F, et al. Among authors: burgio g. BJU Int. 2024 Jul;134(1):48-50. doi: 10.1111/bju.16337. Epub 2024 Mar 14. BJU Int. 2024. PMID: 38482772 No abstract available.
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F, Basile G, de Angelis M, Quarta L, Burgio G, Necchi A, Cigliola A, Chiti A, Picchio M, Salonia A, Briganti A, Montorsi F, Moschini M. Longoni M, et al. Among authors: burgio g. BJU Int. 2024 Oct;134(4):636-643. doi: 10.1111/bju.16363. Epub 2024 Apr 15. BJU Int. 2024. PMID: 38621771
Mitomycin C vs. Bacillus Calmette-Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients-A comparative analysis from a single center.
Scilipoti P, Longoni M, de Angelis M, Re C, Bertini A, Cannoletta D, Burgio G, Lucianò R, Rosiello G, Colombo R, Gandaglia G, Salonia A, Montorsi F, Briganti A, Moschini M. Scilipoti P, et al. Among authors: burgio g. Urol Oncol. 2024 Dec;42(12):451.e1-451.e10. doi: 10.1016/j.urolonc.2024.06.026. Epub 2024 Jul 26. Urol Oncol. 2024. PMID: 39060208
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.
Pellegrino F, Leni R, Basile G, Rosiello G, Re C, Scilipoti P, De Angelis M, Longoni M, Avesani G, Quarta L, Zaurito P, Cattafi F, Burgio G, Gandaglia G, Montorsi F, Briganti A, Moschini M. Pellegrino F, et al. Among authors: burgio g. World J Urol. 2024 Apr 28;42(1):270. doi: 10.1007/s00345-024-04970-x. World J Urol. 2024. PMID: 38679650
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
Moschini M, Afferi L, Gandaglia G, D'Andrea D, Zamboni S, Di Bona C, Mordasini L, Mattei A, Baumeister P, Martini A, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Stabile A, Zaffuto E, Salonia A, Colombo R, Necchi A, Montorsi F, Briganti A, Gallina A. Moschini M, et al. Among authors: burgio g. Eur Urol Focus. 2021 Sep;7(5):1067-1074. doi: 10.1016/j.euf.2020.09.009. Epub 2020 Oct 2. Eur Urol Focus. 2021. PMID: 33020030 Clinical Trial.
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder.
Robesti D, Moschini M, Pio Tenace N, Burgio G, Re C, Leni R, De Angelis M, Scilipoti P, Pellegrino F, Cannoletta D, Gandaglia G, Fossati N, Gallina A, Doglioni C, Colecchia M, Salonia A, Montorsi F, Briganti A, Lucianò R. Robesti D, et al. Among authors: burgio g. Eur Urol Focus. 2024 Jun 26:S2405-4569(24)00096-8. doi: 10.1016/j.euf.2024.06.007. Online ahead of print. Eur Urol Focus. 2024. PMID: 38937195
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.
Moschini M, Martini A, Zamboni S, Mattei A, Baumeister P, Di Bona C, Dell'Oglio P, Zaffuto E, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R. Moschini M, et al. Among authors: burgio g. Clin Genitourin Cancer. 2019 Jun;17(3):e541-e548. doi: 10.1016/j.clgc.2019.02.001. Epub 2019 Feb 13. Clin Genitourin Cancer. 2019. PMID: 30850337
Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience.
Moschini M, Gandaglia G, Dell'Oglio P, Fossati N, Cucchiara V, Burgio G, Mattei A, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A. Moschini M, et al. Among authors: burgio g. Clin Genitourin Cancer. 2016 Aug;14(4):e341-6. doi: 10.1016/j.clgc.2015.12.017. Epub 2015 Dec 23. Clin Genitourin Cancer. 2016. PMID: 26797584
Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
Colombo R, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Lucianò R, Conti G, Magnani T, Capogrosso P, Conti A, Pasini L, Burgio G, Guazzoni G, Patriarca C. Colombo R, et al. Among authors: burgio g. Eur Urol Focus. 2018 Jan;4(1):87-93. doi: 10.1016/j.euf.2016.06.004. Epub 2016 Jun 15. Eur Urol Focus. 2018. PMID: 28753746
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer.
Zaurito P, Scilipoti P, Longoni M, de Angelis M, Re C, Quarta L, Tremolada G, Burgio G, Pellegrino F, Rosiello G, Necchi A, Colombo R, Gandaglia G, Salonia A, Montorsi F, Briganti A, Moschini M. Zaurito P, et al. Among authors: burgio g. World J Urol. 2024 Dec 30;43(1):52. doi: 10.1007/s00345-024-05417-z. World J Urol. 2024. PMID: 39739061